Advice
Following a full submission
posaconazole (Noxafil®) is accepted for restricted use within NHS Scotland for prophylaxis of invasive fungal infections in immunocompromised patients. It is restricted to patients in whom there is a specific risk of Aspergillus infection or where fluconazole or itraconazole are not tolerated.
Download detailed advice57KB (PDF)
Medicine details
- Medicine name:
- posaconazole 40mg/ml oral suspension (Noxafil)
- SMC ID:
- 379/07
- Indication:
- Prophylaxis of invasive fungal infections
- Pharmaceutical company
- Schering-Plough Ltd
- BNF chapter
- Infections
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 11 June 2007